Exact Mass: 333.2456366
Exact Mass Matches: 333.2456366
Found 147 metabolites which its exact mass value is equals to given mass value 333.2456366,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mahanimbinol
Mahanimbinol is found in herbs and spices. Mahanimbinol is an alkaloid from Murraya koenigii (curryleaf tree). Alkaloid from Murraya koenigii (curryleaf tree). Mahanimbinol is found in herbs and spices.
Deptropine
Deptropine is a tricyclic H1-antihistamine.
2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine
Carbetapentane
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].
Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylate
4-[(6E)-3-Hydroxy-8,10-dimethyl-2-(methylamino)-6-dodecen-1-yl]phenol
Malonganenone K|N-[(2E,6E,10E)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl]formamide
Pentoxyverine
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].
4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol
4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol
4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol [IIN-based on: CCMSLIB00000847532]
4-[(E)-3-hydroxy-8,10-dimethyl-2-(methylamino)dodec-6-enyl]phenol [IIN-based: Match]
tert-butyl N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]carbamate
C18H28BNO4 (333.21112780000004)
Saxagliptin hydrate
C18H27N3O3 (333.20523119999996)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
N-(2-(dimethylamino)ethyl)-N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide
C17H28BN3O3 (333.22236080000005)
3,3-(dodecylimino)bispropane-1,2-diol
C18H39NO4 (333.28789340000003)
4-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
C18H28BNO4 (333.21112780000004)
2-(2-Morpholinoethylamino)pyridine-5-boronic acid pinacol ester
C17H28BN3O3 (333.22236080000005)
N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclohexanamine
tert-Butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
C18H28BNO4 (333.21112780000004)
tert-Butyl 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
C18H28BNO4 (333.21112780000004)
TERT-BUTYL4-(2-METHYL-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE
C18H27N3O3 (333.20523119999996)
4-(2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-morpholine
C18H28BNO4 (333.21112780000004)
trans-4-[5-(4-Pentylcyclohexyl)-2-pyrimidinyl]benzonitrile
(2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)ACETICACID
C18H27N3O3 (333.20523119999996)
bis(2-hydroxyethyl)ammonium myristate
C18H39NO4 (333.28789340000003)
4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
C18H28BNO4 (333.21112780000004)
N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOHEXANAMINE
TERT-BUTYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYLCARBAMATE
C18H28BNO4 (333.21112780000004)
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide
C18H27N3O3 (333.20523119999996)
N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one
3-((n-boc-amino)methyl)phenylboronic acid
C18H28BNO4 (333.21112780000004)
octyl 2-acetamido-2-deoxy-b-d-glucopyranoside
C16H31NO6 (333.21512659999996)
tert-butyl N-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate
C18H28BNO4 (333.21112780000004)
1-METHYL-2,5-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE
Isomylamine hydrochloride
C18H36ClNO2 (333.24344260000004)
C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine
deptropine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
(5S,6E,8Z,11Z,14Z,16E,18R)-5,18-dihydroxyicosa-6,8,11,14,16-pentaenoate
(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oate
(5Z,13E,15S)-15-hydroxy-11-oxoprosta-5,9,13-trien-1-oate
octyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside
C16H31NO6 (333.21512659999996)
(7R,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate
(7S,11S,16S)-7-hydroxy-ent-kauran-11,16-epoxy-19-oate
(7E,9E,11Z,13E,15R)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate
(7E,9E,11Z,13E,15S)-(5S,6S)-5,6-epoxyicosa-15-hydroxy-7,9,11,13-tetraenoate
7-[[(3R,4R)-3-(butylsulfanylmethyl)-4-methylpyrrolidin-1-yl]methyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine
(5S,18S)-dihydroxy-(6E,8Z,11Z,14Z,16E)-eicosapentaenoate
1-(2-{4-[(4-Carboxybutanoyl)amino]phenyl}ethyl)-1-methylpiperidinium
5,20-diHEPE(1-)
An icosanoid anion that is the conjugate base of 5,20-di-HEPE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.
12(S)-HpEPE(1-)
A 12-HPEPE anion that is the conjugate base of 12(S)-HpEPE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
15-dehydroprostaglandin A1(1-)
A prostaglandin carboxylic acid anion that is the conjugate base of 15-dehydro-prostaglandin A1, obtained by deprotonation of the carboxy group.; major species at pH 7.3.
12-Hpepe(1-)
A polyunsaturated fatty acid anion that is the conjugate base of 12-HPEPE, obtained by deprotonation of the carboxy group; major species at pH 7.3.
Tert-butyl 2-[3-(mesitylamino)-1-methyl-3-oxopropylidene]hydrazinecarboxylate
C18H27N3O3 (333.20523119999996)
(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oate
(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,11,13-trien-1-oate
(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate
(5Z,8R,9E,11Z,14Z,17Z)-8-hydroperoxyicosa-5,9,11,14,17-pentaenoate
(5Z,12E,15S)-15-hydroxy-11-oxoprosta-5,9,12-trien-1-oate
(5S,6E,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoate
N-(2-hydroxyethyl)nonadeca-7,10,13,16-tetraenamide
1-(5-Methyl-2-propan-2-ylcyclohexyl)oxy-3-(1-phenylethylamino)-2-propanol
N-[(2R)-1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine
(10Z,13Z,16Z)-docosatrienoate
A long-chain polyunsaturated fatty acid anion that is the conjugate base of (10Z,13Z,16Z)-docosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(13Z,16Z,19Z)-Docosatrienoate
A long-chain polyunsaturated fatty acid anion that is the conjugate base of (13Z,16Z,19Z)-docosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
N-[(2S)-1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine
(5S,6Z,8E,10E,12R,14Z,17Z)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoate
14-oxo-15-hydroxy-(5Z,8Z,11Z,17Z)-eicosatetraenoate
(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate
5-(2-(6-Methyl-3-pyridyl)ethyl)-2-propyl-1,2,3,4-tetrahydro-gamma-carboline
2-(4-(8-Chloro-3,7-dimethylocta-2(E),6(E)-dienyl)-1,3,3-trimethyl-1-cyclohexen-2-YL)acetonitrile
prostaglandin J2(1-)
A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin J2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(18S)-resolvin E2(1-)
An icosanoid anion that is the conjugate base of (18S)-resolvin E2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
soppiline A(1-)
A hydroxy monocarboxylic acid anion that is the conjugate base of soppiline A, arising from the deprotonation of the carboxy group. Major species at pH 7.3.
prostaglandin B2(1-)
A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin B2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
prostaglandin C2(1-)
A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin C2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
leukotriene B5(1-)
An icosanoid anion that is the conjugate base of leukotriene B5, obtained by deprotonation of the carboxy group; major species at pH 7.3.
Docosatrienoate
A polyunsaturated fatty acid anion containing 22 carbons and 3 double bonds. Major species at pH 7.3.
resolvin E2(1-)
A polyunsaturated fatty acid anion that is the conjugate base of resolvin E2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
prostaglandin A2(1-)
A prostaglandin carboxylic acid anion resulting from the removal of the proton from the carboxy group of prostaglandin A2.
4-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazol-3-ol
2-[(1-hydroxy-2-methylbutylidene)amino]-n-(2-phenylethyl)pentanediimidic acid
C18H27N3O3 (333.20523119999996)
(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol
(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid
(1s,16s,19r)-19-isopropyl-13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene
n-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl)methanimidic acid
(2s)-2-{[(2r)-1-hydroxy-2-methylbutylidene]amino}-n-(2-phenylethyl)pentanediimidic acid
C18H27N3O3 (333.20523119999996)